Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4228)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 26, 2021 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Naito R, Kasai T. Sodium glucose cotransporter 2 inhibitors: New horizon of the heart failure pharmacotherapy. World J Cardiol 2021; 13(9): 464-471 [PMID: 34621491 DOI: 10.4330/wjc.v13.i9.464] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v13/i9/464.htm |
| Number | Citing Articles |
| 1 |
Mrinal Kanti Guha. SGLT-2 INHIBITORS – AN ANTIDIABETIC WITH CARDIOPROTECTIVE EFFECTS. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 50 doi: 10.36106/ijsr/7904180
|
| 2 |
Andrew Xanthopoulos, Grigorios Giamouzis, John Skoularigis, Filippos Triposkiadis. Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?. World Journal of Cardiology 2022; 14(7): 438-445 doi: 10.4330/wjc.v14.i7.438
|
| 3 |
Ryo Naito, Takatoshi Kasai. One step towards tailor‐made medicine for patients with heart failure. European Journal of Heart Failure 2023; 25(8): 1254 doi: 10.1002/ejhf.2941
|